Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Letue35 

Discuss Cytokinetics Inc.

Cytokinetics Inc.

WKN: A1W1KK / Symbol: CYTK / Name: Cytokinetics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

53,50 €
-2,73 %

41 0
41
0
Einschätzung Buy
Rendite (%) 1,87 %
Kursziel 72,55
Veränderung
Endet am 28.01.27

Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat

Barclays PLC 
0
Melden Teilen
28.01.26
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

TD_Securities in Rogers Communications B diskutieren
Rogers Communication (NYSE:RCI) (TSE:RCI.B) had its "buy...
17:15
TD_Cowen in Rogers Communications B diskutieren
Rogers Communication (NYSE:RCI) (TSE:RCI.B) had its "buy...
17:01
Royal_Bank_of_Canada in Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price targ...
16:45
Wells_Fargo___Compan in PennyMac Financial Services, Inc. diskutieren
PennyMac Financial Services (NYSE:PFSI) had its price tar...
16:45
Wedbush in Innodata Inc. diskutieren
Innodata (NASDAQ:INOD) had its "outperform" rating reaff...
16:15
Lake_Street_Capital in American Public Ed. diskutieren
American Public Education (NASDAQ:APEI) had its "buy" ra...
15:15
Needham___Company_LL in Axos Financial, Inc. diskutieren
Axos Financial (NYSE:AX) had its price target raised by a...
15:02
Needham___Company_LL in Aerovironment diskutieren
AeroVironment (NASDAQ:AVAV) had its "buy" rating reaffir...
15:02
Mehr anzeigen